Australia markets open in 3 hours 55 minutes
  • ALL ORDS

    7,593.80
    +30.70 (+0.41%)
     
  • AUD/USD

    0.7241
    +0.0008 (+0.11%)
     
  • ASX 200

    7,296.90
    +23.10 (+0.32%)
     
  • OIL

    72.00
    +1.51 (+2.14%)
     
  • GOLD

    1,769.10
    -9.10 (-0.51%)
     
  • BTC-AUD

    59,975.71
    +1,450.35 (+2.48%)
     
  • CMC Crypto 200

    1,086.82
    +46.34 (+4.45%)
     

Insights on the Medical Device Validation and Verification Global Market to 2027 - Featuring Charles River, Eurofins Scientific and Intertek Among Others - ResearchAndMarkets.com

·3-min read

DUBLIN, July 30, 2021--(BUSINESS WIRE)--The "Medical Device Validation and Verification - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

Amid the COVID-19 crisis, the global market for Medical Device Validation and Verification estimated at US$516.1 Million in the year 2020, is projected to reach a revised size of US$984.6 Million by 2027, growing at a CAGR of 9.7% over the analysis period 2020-2027.

Mechanical Testing, one of the segments analyzed in the report, is projected to record a 9.1% CAGR and reach US$382 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biological segment is readjusted to a revised 10.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $139.6 Million, While China is Forecast to Grow at 12.9% CAGR

The Medical Device Validation and Verification market in the U.S. is estimated at US$139.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$206.2 Million by the year 2027 trailing a CAGR of 12.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.6% and 8.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.6% CAGR.

EMC / ECI Segment to Record 10% CAGR

In the global EMC / ECI segment, USA, Canada, Japan, China and Europe will drive the 9.3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$73.7 Million in the year 2020 will reach a projected size of US$137.4 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$141.2 Million by the year 2027, while Latin America will expand at a 11.4% CAGR through the analysis period.

Select Competitors (Total 36 Featured):

  • Charles River

  • Element Materials Technology

  • Eurofins Scientific SE

  • Global Services Pte., Ltd

  • Intertek

  • NAMSA

  • Pacific Biolabs

  • QuEST

  • SGS SA

  • Steris Laboratories

  • Sterling Medical Devices

  • Toxikon Corporation

  • TUV SUD AG

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights

  • World Market Trajectories

  • Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

  • UNITED STATES

  • CANADA

  • JAPAN

  • CHINA

  • EUROPE

  • FRANCE

  • GERMANY

  • ITALY

  • UNITED KINGDOM

  • SPAIN

  • RUSSIA

  • REST OF EUROPE

  • ASIA-PACIFIC

  • AUSTRALIA

  • INDIA

  • SOUTH KOREA

  • REST OF ASIA-PACIFIC

  • LATIN AMERICA

  • ARGENTINA

  • BRAZIL

  • MEXICO

  • REST OF LATIN AMERICA

  • MIDDLE EAST

  • IRAN

  • ISRAEL

  • SAUDI ARABIA

  • UNITED ARAB EMIRATES

  • REST OF MIDDLE EAST

  • AFRICA

IV. COMPETITION

For more information about this report visit https://www.researchandmarkets.com/r/1dx6oy

View source version on businesswire.com: https://www.businesswire.com/news/home/20210730005252/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting